Humacyte
HUMA
HUMA
96 hedge funds and large institutions have $72.4M invested in Humacyte in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.55% more ownership
Funds ownership: 17.35% → 19.91% (+2.6%)
15% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 33
74% less call options, than puts
Call options by funds: $266K | Put options by funds: $1.02M
Holders
96
Holding in Top 10
2
Calls
$266K
Puts
$1.02M
Top Buyers
| 1 | +$6.71M | |
| 2 | +$6.22M | |
| 3 | +$3.11M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.79M |
| 5 |
Capstone Investment Advisors
New York
|
+$972K |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$955K | |
| 3 | -$740K | |
| 4 |
Morgan Stanley
New York
|
-$520K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$446K |